Many pharmaceutical manufacturers have learned that the system they initially implemented for compliance is no longer meeting their needs. They’re experiencing some very significant challenges:
- Constant EPCIS, serial number and aggregation errors delaying shipments
- Endless revalidations, buggy patches and custom code fixes
- Hidden costs piling up every quarter
- Unresponsive support when they need it most
Switching track and trace systems is a big decision. This comprehensive guide provides the insight you need to make an informed, low-risk change that positions your business for long-term success.
What's in the guide
- Key considerations to help you transition to a new solution with minimal disruption
- Benchmark data highlighting the main reasons companies are switching track and trace solutions
- Clarifying questions, you need to ask any alternative track and trace provider you may be considering
